title: Centrally administered relaxin-3 induces Fos expression in the osmosensitive areas in rat brain and facilitates water intake.
abstract: The expression of the relaxin-3 gene, detected as a new member of the insulin superfamily using human genomic databases, is abundantly present in the brain and testis. Intracerebroventricularly (icv) administered relaxin-3 stimulates food intake. Icv administered relaxin (identical to relaxin-2 in humans) affects the secretion of vasopressin and drinking behavior. Relaxin-3 partly binds relaxin family peptide receptor 1, which is a specific receptor to relaxin. Thus, we hypothesized that relaxin-3 would have physiological effects in the body fluid balance. However, the effects of relaxin-3 in the body fluid balance remain unknown. In the present study, we revealed that icv administered relaxin-3 induced dense Fos-like immunoreactivity (Fos-LI) in the rat hypothalamus and circumventricular organs including the organum vasculosum of the lamina terminalis, the median preoptic nucleus, supraoptic nucleus (SON), the subfornical organ (SFO) and the paraventricular nucleus (PVN), that are related to the central regulation of body fluid balance. Icv administered relaxin-3 (54, 180 and 540 pmol/rat) also induced a significant increase in c-fos gene expression in a dose-dependent manner in the SON, SFO and PVN. Further, icv administered relaxin-3 (180 pmol/rat) significantly increased water intake, and the effect was as strong as that of relaxin-2 (180 pmol/rat). These results suggest that icv administered relaxin-3 activates osmosensitive areas in the brain and plays an important role in the regulation of body fluid balance.
authors.affiliation: Department of Physiology, School of Medicine, University of Occupational and Environmental Health, 1-1 Iseigaoka, Yahatanishi-ku, Kitakyushu 807-8555, Japan.
authors.forename: Hiroki
authors.initials: H
authors.lastname: Otsubo
authors.forename: Tatsushi
authors.initials: T
authors.lastname: Onaka
authors.forename: Hitoshi
authors.initials: H
authors.lastname: Suzuki
authors.forename: Akiko
authors.initials: A
authors.lastname: Katoh
authors.forename: Toyoaki
authors.initials: T
authors.lastname: Ohbuchi
authors.forename: Miwako
authors.initials: M
authors.lastname: Todoroki
authors.forename: Mizuki
authors.initials: M
authors.lastname: Kobayashi
authors.forename: Hiroaki
authors.initials: H
authors.lastname: Fujihara
authors.forename: Toru
authors.initials: T
authors.lastname: Yokoyama
authors.forename: Tetsuro
authors.initials: T
authors.lastname: Matsumoto
authors.forename: Yoichi
authors.initials: Y
authors.lastname: Ueta
mesh_terms: D000818:Animals; D001921:Brain / Q000187:drug effects / Q000502:physiology*; D004326:Drinking / Q000187:drug effects*; D004327:Drinking Behavior / Q000187:drug effects; D007031:Hypothalamus / Q000187:drug effects; D007276:Injections, Intraventricular; D010286:Paraventricular Hypothalamic Nucleus / Q000187:drug effects; D016760:Proto-Oncogene Proteins c-fos / Q000096:biosynthesis*; D051381:Rats; D012065:Relaxin / Q000494:pharmacology*; D013356:Subfornical Organ / Q000187:drug effects; D013495:Supraoptic Nucleus / Q000187:drug effects; D014882:Water-Electrolyte Balance / Q000502:physiology*
chemical_list: D016760:Proto-Oncogene Proteins c-fos; C095068:RLN2 protein, human; C480238:RLN3 protein, human; D012065:Relaxin